June 20, 2025 C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury C-Path, through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain...
June 20, 2025 C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...
June 18, 2025 C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes C-Path's Translational Therapeutics Accelerator (TRxA) proudly announced a $250,000 grant...
June 17, 2025-June 18, 2025 Workshop: 21st Century Trials in New-Onset T1D Critical Path Institute’s Type 1 Diabetes consortium held a virtual workshop...
June 17, 2025 Honoring Progress and Hope Amidst Alzheimer’s and Brain Awareness Month Each June, we come together to recognize Alzheimer’s and Brain Awareness Month—a time to raise visibility for the 55 million..
June 16, 2025 New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects The paper, by authors from IHI and the Critical Path Institute, highlights the importance of a structured, strategic...
June 13, 2025 When The Game Changed: What Chronic Kidney Disease Taught Me About Men’s Health Seeing as how this is a C-Path piece, I suppose it may be prudent to introduce myself to those in our community...
June 9, 2025 Delivering regulatory impact from consortium-based projects Multiple consortia have been established in the past two decades with the aim of tackling roadblocks in the development of...
